Wang G, Sweren E, Liu H, Wier E, Alphonse MP, Chen R, Islam N, Li A, Xue Y, Chen J, Park S, Chen Y, Lee S, Wang Y, Wang S, Archer NK, Andrews W, Kane MA, Dare E, Reddy SK, Hu Z, Grice EA, Miller LS, Garza LA (2021) Bacteria induce skin regeneration via IL-1 signaling
They can help weigh the potential benefits against the risk of losing progress, based on where you are in your journey
Dive Brief: Amgens experimental obesity drug MariTide helped people with obesity lose an average of up to 16% of their body weight over the course of a year, according to full data from a Phase 2 trial unveiled Monday at a medical meeting
Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP)
For context, in one study of 175 people with overweight or obesity, participants taking semaglutide: Lost an average of 15 pounds (about 6% of their body weight) within three months Lost an average of 27 pounds (about 11% of their body weight) after six months Recommended lifestyle changes during GLP-1 therapy GLP-1 medications can boost weight loss by increasing satiety and reducing food cravings
Several GLP-1 receptor agonists are FDA-approved for type 2 diabetes management and, in some cases, chronic weight management
